Therapeutic Asset Ratings

436 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Palbociclib Advanced Solid Tumors	Bristol-Myers Squibb	P2	B (58)
Talzenna Advanced Solid Tumors	National Cancer Institute (NCI)	P3	B (57)
Daunorubicin Advanced Solid Tumors	Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.	P3	B (56)
Adebrelimab Advanced Solid Tumors	Hansoh BioMedical R&D Company	P2	B (56)
Olaparib Advanced Solid Tumors	Daewoong Pharmaceutical Co. LTD.	P2	B (56)
S-1 Advanced Solid Tumors	University of Malaya	P2/3	B (56)
TAMOXIFEN Advanced Solid Tumors	Merck Sharp & Dohme LLC	P2/3	B (56)
cc-5013 Advanced Solid Tumors	CStone Pharmaceuticals	P2	CCC (55)
LEUPROLIDE Advanced Solid Tumors	OnKure, Inc.	P2	CCC (55)
Panobinostat Advanced Solid Tumors	Asan Medical Center	P2	CCC (55)
Temsirolimus Advanced Solid Tumors	M.D. Anderson Cancer Center	P2	CCC (55)
1H-BENZIMIDAZOLE, 2-(((4-(3-METHOXYPROPOXY)-3-METHYL-2-PYRIDINYL)METHYL)SULFINYL)-, SODIUM SALT, HYDRATE (1:1:1) Advanced Solid Tumors	Bristol-Myers Squibb	P1/2	CCC (55)
Adebelimab Advanced Solid Tumors	Shandong Suncadia Medicine Co., Ltd.	P2	CCC (54)
Fluzoparib Advanced Solid Tumors	Risen (Suzhou) Pharma Tech Co., Ltd.	P2	CCC (54)
Iparomlimab Advanced Solid Tumors	Qilu Pharmaceutical Co., Ltd.	P2	CCC (54)
Shr-1826 Advanced Solid Tumors	Shandong Suncadia Medicine Co., Ltd.	P2	CCC (54)
Shr-9839 Advanced Solid Tumors	Shandong Suncadia Medicine Co., Ltd.	P2	CCC (54)
Shr-A2102 Advanced Solid Tumors	Shandong Suncadia Medicine Co., Ltd.	P2	CCC (54)
Ensartinib Advanced Solid Tumors	Li Zhang, MD	P2	CCC (53)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER Advanced Solid Tumors	Seoul National University Bundang Hospital	P2	CCC (53)
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER Advanced Solid Tumors	MedImmune LLC	P2	CCC (53)
Retifanlimab Advanced Solid Tumors	Incyte Corporation	P1/2	CCC (53)
bdb001 Advanced Solid Tumors	HighField Biopharmaceuticals Corporation	P1/2	CCC (52)
m3814 Advanced Solid Tumors	Telix Pharmaceuticals (Innovations) Pty Limited	P1/2	CCC (52)
Ribociclib Advanced Solid Tumors	OnKure, Inc.	P1/2	CCC (52)

Showing 26 to 50 of 436 assets

PreviousPage 2 of 18Next